AGSAVI
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AGSAVI, covering 2020-12-29 to 2026-06-18. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS [Phase 3]